A semi-autonomous AI agent team using a 246M-parameter graph diffusion model generated 5,231 novel molecules across two oncology targets, with 91.9% new Murcko scaffolds and strong predicted binding performance.
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.The Lancet Oncology, 21(11):1433–1442, November
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.AI 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Rhizome OS-1: Rhizome's Semi-Autonomous Operating System for Small Molecule Drug Discovery
A semi-autonomous AI agent team using a 246M-parameter graph diffusion model generated 5,231 novel molecules across two oncology targets, with 91.9% new Murcko scaffolds and strong predicted binding performance.